PMEF
DALS

Point72 Middle East FZE’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Point72 Middle East FZE’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,609
Closed -$119K – 2016
2023
Q2 		$119K Sell
11,609
-171
-1% -$1.75K ﹤0.01% 1177
2023
Q1 		$119K Sell
11,780
-259
-2% -$2.61K ﹤0.01% 1071
2022
Q4 		$120K Buy
+12,039
New +$119K 0.01% 1214

Point72 Middle East FZE's DALS Position: Q3 2023 in Review

Point72 Middle East FZE sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 11,609 shares — an estimated $119K sold.

Point72 Middle East FZE first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $120K in Q4 2022. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Point72 Middle East FZE reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 11,609 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $119K.
  • Point72 Middle East FZE first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $120K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.